Genentech (Roche)
Genentech (Roche)

Genentech (Roche)

Measured by AhrefsDR82 out of 100, Top 25%. Ahrefs DR. Open the scores section.Ahrefs DR: 82/100. Top 25%. Measured by Ahrefs. Median 44.Measured by StartupHub.aiAgent31 out of 100, Below median. Agent Readiness. Open the scores section.Agent Readiness: 31/100. Below median. Measured by StartupHub.ai. Median 41.Measured by Google PageSpeedSpeed51 out of 100, Below median. Site Speed. Open the scores section.Site Speed: 51/100. Below median. Measured by Google PageSpeed. Median 62.Measured by StartupHub.aiTrust93 out of 100, Top 25%. Data Trust. Open the scores section.Data Trust: 93/100. Top 25%. Measured by StartupHub.ai. Median 61.

Pioneering biotechnology company focused on discovering, developing, manufacturing, and commercializing medicines to treat patients with serious or life-threatening medical conditions.

1976ActiveSouth San Francisco, United States

We may earn a commission from links on this Genentech (Roche) profile. That does not change the facts we publish.

About

Genentech is a leading biotechnology company that uses human genetic information to discover, develop, manufacture, and commercialize medicines to treat patients with serious or life-threatening medical conditions. Founded in 1976, it pioneered the biotechnology industry and has since been at the forefront of scientific innovation, developing groundbreaking therapies in areas like cancer, immunology, and neuroscience.

Competitors & Alternatives (6)

Similar companies

LT
LTZ Therapeutics
LTZ Therapeutics

Immunotherapy company targeting oncology and autoimmune diseases.

Shares Biotechnology, HealthTech

MB
Manifold Bio
Manifold Bio

AI-guided drug discovery platform for tissue-targeted medicines.

Shares Biotech, Drug Discovery

TB
TippingPoint Biosciences
TippingPoint Biosciences

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Shares Biotech, Drug Discovery

HB
Hexagon Bio
Hexagon Bio

Developing novel therapeutics by understanding the complex interplay of biological systems.

Shares Biotech, Drug Discovery

AB
Avidity Biosciences
Avidity Biosciences

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

Shares Biotech, Drug Discovery

AT
Adaptam Therapeutics
Adaptam Therapeutics

Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.

Shares Biotech, Drug Discovery

Key facts

Website
gene.com
Headquarters
South San Francisco, United States
Founded
1976
Business model
B2B

Tech stack

Detected on gene.com, last scanned 29 Oct 2026.

Frontend
jQuery
Analytics
Google Tag Manager
CMS / Builders
Salesforce
CDN
Cloudflare
Email provider
SendGrid
Cookie consent
OneTrust
Hiring platform
Phenom
Affiliate program
Self-hosted affiliate
Run your own scan

Test your Ahrefs DR

The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.

Write the first review

Frequently asked

Is Genentech (Roche) trustworthy and reputable?

StartupHub's Data Trust & Reputation score for Genentech (Roche) is 93 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.

Does Genentech (Roche) have an affiliate program?

Yes, Genentech (Roche) has an affiliate program. The program runs on Self-hosted affiliate. Register here: www.gene.com/affiliates

SEC filings, insider activity, nonprofit links and pay benchmarks for Genentech (Roche):

Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules